Thursday Jul 24
Asterias Biotherapeutics Announces Live Investor Webcast
Asterias Biotherapeutics, Inc. , a leading biotechnology company in the emerging field of regenerative medicine, announced today that it will host a live webcast of a presentation to investors on Tuesday, July 29, 2014, at 4:30 p.m. EDT, 1:30 p.m. PDT.
BioTime Announces Issuance of 14 Patents in the Fields of...
BioTime , Inc. announced today the issuance of 14 new patents to BioTime and its subsidiary companies.
Biggest Movers: MannKind Corporation, NetApp Inc., and Geron Corporation
At last check, the shares were trading 11.1% higher at $11.11, and speculators on both sides of the options pits were exchanging contracts at roughly four times the expected intraday rate.
Geron Set To Explode As FDA Releases Partial Clinical Hold On Imetelstat Myelofibrosis Trial
The lift of the Mayo Clinic myelofibrosis partial clinical hold practically guarantees hold will be lifted off Geron sponsored myelofibrosis Phase II trial initiation.